Dario Coletti

Pubblicazioni

Titolo Pubblicato in Anno
Editorial: Myokines, Adipokines, Cytokines in Muscle Pathophysiology FRONTIERS IN PHYSIOLOGY 2020
Exercise reduces the resumption of tumor growth and proteolytic pathways in the skeletal muscle of mice following chemotherapy CANCERS 2020
The Mechanical Stimulation of Myotubes Counteracts the Effects of Tumor-Derived Factors Through the Modulation of the Activin/Follistatin Ratio MYOKINES, ADIPOKINES, CYTOKINES IN MUSCLE PATHOPHYSIOLOGY 2020
Skeletal muscle regeneration is impaired in patients with cancer-associated cachexia Virtual Cancer Cachexia Conference 2020
SRF-mediated mechanotransduction is essential for the response to exercise in cancer patients and animal models Virtual Cancer Cachexia Conference 2020 2020
Central myonuclei and denervation markers in cancer cachexia EUROPEAN JOURNAL OF TRANSLATIONAL MYOLOGYEUROPEAN JOURNAL OF TRANSLATIONAL MYOLOGY 2020
Skeletal muscle: a significant novel neurohypophyseal hormone-secreting organ FRONTIERS IN PHYSIOLOGY 2019
The mechanical stimulation of myotubes counteracts the effects of tumor-derived factors through the modulation of the activin/follistatin ratio FRONTIERS IN PHYSIOLOGY 2019
Vitamin D, muscle recovery, sarcopenia, cachexia, and muscle atrophy NUTRITION 2019
Srf KO and wild-type mice similarly adapt to endurance exercise EUROPEAN JOURNAL OF TRANSLATIONAL MYOLOGY 2019
Human cachexia induces changes in mitochondria, autophagy and apoptosis in the skeletal muscle CANCERS 2019
Muscle acellular scaffold provides a multipotent environment for regenerative interventions following volumetric muscle loss and regeneration of other tissues of mesenchymal origin Building, repairing, replacing organs 2019
SRF role as a mechano-transductor in response to exercise in cancer cachexia JOURNAL OF CACHEXIA, SARCOPENIA AND MUSCLEJOURNAL OF CACHEXIA, SARCOPENIA AND MUSCLE 2019
The mechanical stimulation of myotubes counteracts the effects of tumor-derived factors through IL-4 secretion and the modulation of the activin/follistatin ratio JOURNAL OF CACHEXIA, SARCOPENIA AND MUSCLEJOURNAL OF CACHEXIA, SARCOPENIA AND MUSCLE 2019
Ormoni neuroipofisari: regolatori non canonici della struttura, funzione e omeostasi del muscolo L'ENDOCRINOLOGO 2018
Increasing autophagy does not affect neurogenic muscle atrophy EUROPEAN JOURNAL OF TRANSLATIONAL MYOLOGY 2018
Revisiting the peculiar regional distribution of muscle fiber types in rat sternomastoid muscle EUROPEAN JOURNAL OF TRANSLATIONAL MYOLOGY 2018
Chemotherapy-induced muscle wasting: an update EUROPEAN JOURNAL OF TRANSLATIONAL MYOLOGY 2018
Mesenchymal stem cells as promoters, enhancers, and playmakers of the translational regenerative medicine 2018 STEM CELLS INTERNATIONAL 2018
Muscle spindles of the rat sternomastoid muscle EUROPEAN JOURNAL OF TRANSLATIONAL MYOLOGY 2018

ERC

  • LS3
  • LS3_2
  • LS3_5
  • LS3_9
  • LS3_13
  • LS4
  • LS4_9
  • LS4_10
  • LS4_12
  • LS7
  • LS7_4
  • LS7_6

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

For additional, informal information on my research interest, please visit the blog pages:

https://dariocolettithescientist.blogspot.com/

  1. Pharmacological, physiological, and nutritional interventions against cachexia: My laboratory is focused on different approaches to counteract cancer cachexia, including pharmacological (exercise mimetics), physiological (physical activity), and nutritional (supplements) interventions in humans and animal models.
    1. Chiappalupi S et al. (2020) J Cachexia Sarcopenia Muscle;11(4):929-946. doi: 10.1002/jcsm.12561. Epub 2020 Mar 11. PMID: 32159297 xxx
    2. Baccam A, et al. (2019) Front Physiol;10:401. PMID: 31068826
    3. Garcia M, et al. (2019) VNutrition; 60:66-69. PMID: 30529188
    4. Pigna E, et al. (2016) Sci Rep; 6:26991. PMID: 27244599
    5. Carotenuto F, et al.(2016)  Int J Med Sci;13(3):206-19. PMID: 26941581          
  2. Patents and technology transfer: I am co-inventor of a patented procedure to produce Hsp60-enriched exosomes with exercise-mimetic activity, a product that is, therefore, called Physiactisome. Patent: Physiactisome – «Procedure for the synthesis of HSP-containing exosomes and their use against muscle atrophy and cachexia» - patent n. 102018000009235 on 8/10/2018, deposited by Università di Palermo. Owners: Università di Palermo, Università di Roma La Sapienza, Nanovector Torino, Sorbonne Université. List of inventors: Valentina Di Felice, et al. International publication number WO 2020/075004 A1. This product can be exploited against muscle atrophy, since it ameliorates muscle endurance and homeostasis. The presentation of the product and the corresponding Spinoff project (iBioTHEx) was awarded the third prize (5000 Euro) at the EIT JumpStarter Grand final, Health category, Riga, Latvia, 15-17/11/2019

    1. Barone R, et al.(2016) Sci Rep; 6:19781. PMID: 26812922
  3. Pathophysiology of muscle tissues: I contribute to discovering and explaining those mechanisms underlying pathologies of the striated and smooth muscle tissues; this activity is carried out at Sorbonne University by using genetic murine models.
    1. Tannous C, et al. (2021) Int J Mol Sci;22(7):3534. PMID: 33805532
    2. Langlois B, (2017) Sci Rep; 7(1):11628. PMID: 28912461
    3. Galmiche G, (2013) Circ Res;112(7):1035-45, 2013

Keywords

cancer cachexia
striated muscles
homeostasis
muscle satellite cells
muscular distrophy of Duchenne/Becker

Gruppi di ricerca - Responsabile

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma